GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Jun2026]
GLENMARK PHARMACEUTICALS Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹4,018 Cr | ₹3,771 Cr | ₹3,901 Cr | ₹6,047 Cr | ₹3,264 Cr | ₹3,256 Cr | ₹3,388 Cr | ₹3,434 Cr |
| Expenses | ₹3,214 Cr | ₹3,008 Cr | ₹3,031 Cr | ₹3,687 Cr | ₹2,684 Cr | ₹2,695 Cr | ₹2,787 Cr | ₹2,832 Cr |
| Operating Income | ₹805 Cr | ₹763 Cr | ₹870 Cr | ₹2,360 Cr | ₹581 Cr | ₹561 Cr | ₹600 Cr | ₹602 Cr |
| Other Income | ₹66 Cr | ₹189 Cr | ₹44 Cr | ₹201 Cr | ₹26 Cr | ₹12 Cr | ₹31 Cr | ₹39 Cr |
| Interest | ₹54 Cr | ₹43 Cr | ₹41 Cr | ₹66 Cr | ₹58 Cr | ₹67 Cr | ₹52 Cr | ₹48 Cr |
| Depreciation | ₹173 Cr | ₹148 Cr | ₹154 Cr | ₹141 Cr | ₹130 Cr | ₹125 Cr | ₹123 Cr | ₹120 Cr |
| Profit Before Tax | ₹643 Cr | ₹388 Cr | ₹534 Cr | ₹967 Cr | ₹96 Cr | ₹8 Cr | ₹456 Cr | ₹473 Cr |
| Profit After Tax | ₹483 Cr | ₹301 Cr | ₹403 Cr | ₹610 Cr | ₹47 Cr | ₹4 Cr | ₹348 Cr | ₹354 Cr |
| EPS | ₹17.11 | ₹10.68 | ₹14.29 | ₹21.63 | ₹1.66 | ₹0.16 | ₹12.33 | ₹12.55 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLENMARK PHARMACEUTICALS | 5% | 1% | 7.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 0.5% | 14% |
| DIVIS LABORATORIES | -0.9% | 21.1% | 25.6% |
| TORRENT PHARMACEUTICALS | -1.3% | 1.1% | 32.7% |
| CIPLA | 0.2% | 2.1% | -5.1% |
| DR REDDYS LABORATORIES | 0.2% | -7.7% | -7.5% |
| MANKIND PHARMA | -1.4% | -3.7% | -5.3% |
| LUPIN | -0.7% | -5.7% | 24% |
| ZYDUS LIFESCIENCES | -0.1% | -3.9% | 14.1% |
GLENMARK PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 6.57 % |
| Y-o-Y | 23.10 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹4,018 Cr | 6.57 | |
| Mar2026 | ₹3,771 Cr | -3.33 | |
| Dec2025 | ₹3,901 Cr | -35.49 | |
| Sep2025 | ₹6,047 Cr | 85.23 | |
| Jun2025 | ₹3,264 Cr | 0.25 | |
| Mar2025 | ₹3,256 Cr | -3.88 | |
| Dec2024 | ₹3,388 Cr | -1.35 | |
| Sep2024 | ₹3,434 Cr | - | |
GLENMARK PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 5.53 % |
| Y-o-Y | 38.63 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹805 Cr | 5.53 | |
| Mar2026 | ₹763 Cr | -12.32 | |
| Dec2025 | ₹870 Cr | -63.14 | |
| Sep2025 | ₹2,360 Cr | 306.45 | |
| Jun2025 | ₹581 Cr | 3.47 | |
| Mar2025 | ₹561 Cr | -6.53 | |
| Dec2024 | ₹600 Cr | -0.28 | |
| Sep2024 | ₹602 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -0.94 % |
| Y-o-Y | 12.65 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 20.03% | -0.94 | |
| Mar2026 | 20.22% | -9.33 | |
| Dec2025 | 22.3% | -42.85 | |
| Sep2025 | 39.02% | 119.46 | |
| Jun2025 | 17.78% | 3.19 | |
| Mar2025 | 17.23% | -2.77 | |
| Dec2024 | 17.72% | 1.08 | |
| Sep2024 | 17.53% | - | |
GLENMARK PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 60.24 % |
| Y-o-Y | 927.88 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹483 Cr | 60.24 | |
| Mar2026 | ₹301 Cr | -25.27 | |
| Dec2025 | ₹403 Cr | -33.94 | |
| Sep2025 | ₹610 Cr | 1,199.54 | |
| Jun2025 | ₹47 Cr | 971.46 | |
| Mar2025 | ₹4 Cr | -98.74 | |
| Dec2024 | ₹348 Cr | -1.82 | |
| Sep2024 | ₹354 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 50.44 % |
| Y-o-Y | 734.72 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 12.02 % | 50.44 | |
| Mar2026 | 7.99 % | -22.73 | |
| Dec2025 | 10.34 % | 2.38 | |
| Sep2025 | 10.1 % | 601.39 | |
| Jun2025 | 1.44 % | 1,007.69 | |
| Mar2025 | 0.13 % | -98.73 | |
| Dec2024 | 10.27 % | -0.48 | |
| Sep2024 | 10.32 % | - | |
GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 60.21 % |
| Y-o-Y | 930.72 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹17.11 | 60.21 | |
| Mar2026 | ₹10.68 | -25.26 | |
| Dec2025 | ₹14.29 | -33.93 | |
| Sep2025 | ₹21.63 | 1,203.01 | |
| Jun2025 | ₹1.66 | 937.50 | |
| Mar2025 | ₹0.16 | -98.70 | |
| Dec2024 | ₹12.33 | -1.75 | |
| Sep2024 | ₹12.55 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD